You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: April 24, 2024

Dexamethasone sodium phosphate - Generic Drug Details

✉ Email this page to a colleague

« Back to Dashboard

What are the generic sources for dexamethasone sodium phosphate and what is the scope of freedom to operate?

Dexamethasone sodium phosphate is the generic ingredient in thirteen branded drugs marketed by Ucb Inc, Merck, Cent Pharms, Abraxis Pharm, Fresenius Kabi Usa, Amneal, Bel Mar, Dell Labs, Dr Reddys, Epic Pharma Llc, Eugia Pharma, Geneyork Pharms, Gland Pharma Ltd, Hikma, Intl Medication, Luitpold, Lyphomed, Mylan Labs Ltd, Somerset, Somerset Theraps Llc, Teva Parenteral, Watson Labs, West-ward Pharms Int, Wyeth Ayerst, Aspen Global Inc, Pharmafair, Alcon, Sola Barnes Hind, Bausch And Lomb, Sandoz, and Alcon Pharms Ltd, and is included in fifty-nine NDAs. Additional information is available in the individual branded drug profile pages.

There are eleven drug master file entries for dexamethasone sodium phosphate. Eighteen suppliers are listed for this compound.

Summary for dexamethasone sodium phosphate

US Patents:	0
Tradenames:	13
Applicants:	31
NDAs:	59
Drug Master File Entries:	11
Finished Product Suppliers / Packagers:	18
Raw Ingredient (Bulk) Api Vendors:	87
Clinical Trials:	64
Patent Applications:	6,699
Formulation / Manufacturing:	see details
What excipients (inactive ingredients) are in dexamethasone sodium phosphate?	dexamethasone sodium phosphate excipients list
DailyMed Link:	dexamethasone sodium phosphate at DailyMed

Recent Clinical Trials for dexamethasone sodium phosphate

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
Andrew E. Place	Phase 1
Children's Cancer Research Fund	Phase 1
Yale University	Phase 2

See all dexamethasone sodium phosphate clinical trials

Pharmacology for dexamethasone sodium phosphate

Drug Class	Corticosteroid
Mechanism of Action	Corticosteroid Hormone Receptor Agonists

US Patents and Regulatory Information for dexamethasone sodium phosphate

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Try a Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Pharmafair	DEXAIR	dexamethasone sodium phosphate	SOLUTION/DROPS;OPHTHALMIC	088433-001	Dec 15, 1983		DISCN	No	No	⤷ Try a Trial	⤷ Try a Trial				⤷ Try a Trial
Somerset	DEXAMETHASONE SODIUM PHOSPHATE	dexamethasone sodium phosphate	INJECTABLE;INJECTION	207521-001	Jun 8, 2018	AP	RX	No	No	⤷ Try a Trial	⤷ Try a Trial				⤷ Try a Trial
Intl Medication	DEXAMETHASONE SODIUM PHOSPHATE	dexamethasone sodium phosphate	INJECTABLE;INJECTION	088522-001	Feb 17, 1984		DISCN	No	No	⤷ Try a Trial	⤷ Try a Trial				⤷ Try a Trial
Epic Pharma Llc	DEXAMETHASONE SODIUM PHOSPHATE	dexamethasone sodium phosphate	INJECTABLE;INJECTION	084493-001	Approved Prior to Jan 1, 1982		DISCN	No	No	⤷ Try a Trial	⤷ Try a Trial				⤷ Try a Trial
Abraxis Pharm	DEXAMETHASONE	dexamethasone sodium phosphate	INJECTABLE;INJECTION	088448-001	Jan 25, 1984		DISCN	No	No	⤷ Try a Trial	⤷ Try a Trial				⤷ Try a Trial
Amneal	DEXAMETHASONE SODIUM PHOSPHATE PRESERVATIVE FREE	dexamethasone sodium phosphate	INJECTABLE;INJECTION	208690-001	Aug 22, 2018	AP	RX	No	No	⤷ Try a Trial	⤷ Try a Trial				⤷ Try a Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.